Finzati - Logo
QGEN logo

Qiagen N.V.

QGENMedical - Diagnostics & Research
$43.47
-0.39 (-0.89%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$9.08B
Growth
10.7%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 20.3%Positive free cash flow · 2.18Consistent free cash flow · 5/5Manageable debt level · 0.44Healthy liquidity · 3.9
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:42 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$43.47
Change-0.89%
Shares Out208.94M
Market Cap$9.08B
Enterprise Value$10.08B
52W Range32.53 - 57.82
Beta0.64
P/E22.58
P/S4.33
P/B2.73
P/FCF22.45
EV/Sales4.80

Investment DNA

How strong this company looks for long-term investors

75
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
93/100
Growth Potential
Revenue and expansion
37/100
Price Attractiveness
Cheap or expensive today
68/100
Why this score
Stable or improving margins · 20.3%Positive free cash flow · 2.18Consistent free cash flow · 5/5Manageable debt level · 0.44Healthy liquidity · 3.9Negative growth trend

Analyst view

Analyst sentiment and price target

QGEN
Analyst sentiment
Based on 30 analyst votes · 2026-09-05
72/100
Bullish
Bullish
13
Hold
17
Bearish
0
Price Target
2026-08-07
Low
$36.00
Mean
$43.12
Median
$43.00
High
$52.00

Company Overview

IPO: 6/28/1996
Industry: Medical - Diagnostics & Research
P/B i: 2.73
Debt / Equity i: 0.44
Operating Margin: 24.90%
Net Margin: 20.33%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.44
Current Ratio: 3.90
Quick Ratio: 3.31
Status: Strong
🧾

No insider activity

No recent insider transactions available.